EGFR and lung carcinoma: Also, when used to detect mutations in FNA samples from lung cancer metastatic specimens in lymph nodes, several mutations were found, including EGFR (34%), KRAS (8%), BRAF (3%), PIK3CA (9%), and TP53 (36%) [64].